EyePoint (EYPT) Share-based Compensation (2010 - 2026)

EyePoint (EYPT) reported Share-based Compensation of $58.3 million for Q1 2026, up 6356.26% on a YoY basis from $903000.0 in Q1 2025, and up 2464.89% sequentially from $2.3 million in Q4 2025.

EyePoint (EYPT) Share-based Compensation (2010 - 2026) Analysis & Trends

EyePoint (EYPT) has 17 years of Share-based Compensation data on file, last reported at $58.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Share-based Compensation rose 6356.26% year-over-year to $58.3 million; the trailing twelve-month figure through Mar 2026 stood at $58.3 million (up 260.52% YoY), and the FY2025 full-year result was $21.3 million, down 42.03% from the prior year.
  • Share-based Compensation grew to $58.3 million in Q1 2026, from $2.3 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $58.3 million in Q1 2026 to a low of -$8.5 million in Q4 2023.
  • A 5-year average of $6.2 million and a median of $3.2 million in 2022 frame the typical range for Share-based Compensation.
  • Across the five-year window, Share-based Compensation surged 67120.0% in 2022 and plunged 351.92% in 2023, its largest moves.
  • Tracing EYPT's Share-based Compensation over 5 years: stood at $3.4 million in 2022, then sank by 351.92% to -$8.5 million in 2023, then soared by 193.3% to $7.9 million in 2024, then slumped by 71.23% to $2.3 million in 2025, then soared by 2464.89% to $58.3 million in 2026.
  • Business Quant data shows EYPT's Share-based Compensation at $58.3 million in Q1 2026, $2.3 million in Q4 2025, and -$132000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 6.39 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9.26 Mn
4 NuCana 279.75 Bn 279.75 Bn - 1.18 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 166.40 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 257.40 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 87.30 Mn
10 EyePoint 358.61 Mn 136.07 Mn 168,000.00 58.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 58.30 Mn
Mar 31, 2026 58.30 Mn
Dec 31, 2025 2.27 Mn
Dec 31, 2025 2.27 Mn
Sep 30, 2025 -132,000.00
Sep 30, 2025 -132,000.00
Jun 30, 2025 6.43 Mn
Jun 30, 2025 6.43 Mn
Mar 31, 2025 903,000.00
Mar 31, 2025 903,000.00
Dec 31, 2024 7.90 Mn
Dec 31, 2024 7.90 Mn
Sep 30, 2024 7.45 Mn
Sep 30, 2024 7.45 Mn
Jun 30, 2024 -78,000.00
Jun 30, 2024 -78,000.00
Mar 31, 2024 12.70 Mn
Mar 31, 2024 12.70 Mn
Dec 31, 2023 -8.47 Mn
Dec 31, 2023 -8.47 Mn